| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | QNST | United States | $14.26 | $282,140,000.00 | Buy | 4 | 2009 |
#2 | TBLA | United States | $3.42 | $1,912,040,000.00 | Strong Buy | 4 | 2021 |
#3 | HL | United States | $16.84 | $645,957,000.00 | Buy | 8 | 2002 |
#4 | CDE | United States | $17.40 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#5 | BCRX | United States | $8.32 | $25,186,000.00 | Strong Buy | 11 | 1995 |
#6 | PRMB | United States | $19.35 | $6,664,000,000.00 | Buy | 9 | 2025 |
#7 | DEC | United States | $13.46 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#8 | SRTA | United States | $5.11 | $197,141,000.00 | Strong Buy | 4 | 2019 |
#9 | ORN | United States | $8.32 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#10 | EVER | United States | $18.72 | $163,349,000.00 | Strong Buy | 5 | 2018 |
#11 | MUX | Canada | $17.83 | $197,553,000.00 | Strong Buy | 4 | 1994 |
#12 | MIR | United States | $14.27 | $0.00 | Strong Buy | 8 | 2020 |
#13 | ZVRA | United States | $11.33 | $106,470,000.00 | Strong Buy | 5 | 2015 |
#14 | BXMT | United States | $12.38 | $0.00 | Buy | 5 | 1998 |
#15 | NTST | United States | $17.96 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#16 | GDRX | United States | $3.25 | $796,853,000.00 | Buy | 9 | 2020 |
#17 | BANC | United States | $17.30 | $1,818,792,000.00 | Strong Buy | 9 | 2002 |
#18 | NCNO | United States | $18.18 | $594,781,000.00 | Buy | 16 | 2022 |
#19 | RUN | United States | $7.59 | $858,578,000.00 | Buy | 20 | 2015 |
#20 | PUMP | United States | $9.10 | $1,269,158,000.00 | Buy | 7 | 2017 |
#21 | NMRK | United States | $12.44 | $3,294,024,000.00 | Buy | 5 | 2017 |
#22 | ALHC | United States | $7.89 | $3,948,719,000.00 | Buy | 8 | 2021 |
#23 | BBOT | United States | $3.95 | $0.00 | Strong Buy | 7 | 2024 |
#24 | SI | United States | $18.17 | $47,317,000.00 | Strong Buy | 5 | 2025 |
#25 | OMDA | United States | $18.73 | $260,210,000.00 | Buy | 11 | 2025 |
#26 | PTEN | United States | $10.62 | $4,826,624,000.00 | Buy | 10 | 1995 |
#27 | MPLT | United States | $10.23 | $0.00 | Strong Buy | 7 | 2025 |
#28 | SABS | United States | $3.27 | $0.00 | Strong Buy | 4 | 2020 |
#29 | EVMN | United States | $8.39 | $13,000,000.00 | Strong Buy | 10 | 2025 |
#30 | FA | United States | $17.96 | $1,574,389,000.00 | Buy | 4 | 2021 |
#31 | CALY | United States | $14.24 | $2,060,100,000.00 | Buy | 4 | 1994 |
#32 | AVTX | United States | $15.00 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#33 | NUVB | United States | $5.59 | $62,902,000.00 | Strong Buy | 8 | 2020 |
#34 | ACRS | United States | $5.17 | $1,683,000.00 | Strong Buy | 5 | 2015 |
#35 | COMP | United States | $8.97 | $6,961,600,000.00 | Strong Buy | 10 | 2021 |
#36 | BIOA | United States | $7.11 | $8,995,000.00 | Strong Buy | 6 | 2024 |
#37 | ARVN | United States | $7.39 | $262,600,000.00 | Buy | 19 | 2018 |
#38 | CADL | United States | $10.59 | $125,000.00 | Strong Buy | 7 | 2021 |
#39 | MFA | United States | $7.98 | $0.00 | Buy | 6 | 1998 |
#40 | AGNC | United States | $9.41 | $0.00 | Buy | 13 | 2008 |
#41 | SOC | United States | $3.51 | $0.00 | Buy | 4 | 2021 |
#42 | KRMD | United States | $3.02 | $41,127,366.00 | Strong Buy | 4 | 2019 |
#43 | UTI | United States | $18.65 | $835,616,000.00 | Strong Buy | 4 | 2003 |
#44 | VLY | United States | $12.57 | $0.00 | Strong Buy | 13 | 1994 |
#45 | RLMD | United States | $3.75 | $13,070.00 | Strong Buy | 5 | 2012 |
#46 | MAMA | United States | $12.75 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#47 | REAL | United States | $8.76 | $692,845,000.00 | Buy | 8 | 2019 |
#48 | PHAT | United States | $7.31 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#49 | IRT | United States | $14.63 | $657,696,000.00 | Buy | 10 | 2009 |
#50 | EVLV | United States | $4.66 | $145,905,000.00 | Strong Buy | 4 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (September 30, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.